Details

Autor(en) / Beteiligte

• Vanichanan, Jakapat
• Salazar, Lucrecia
• Wootton, Susan H
• Aguilera, Elizabeth
• Garcia, Melissa N
• Murray, Kristy O
• Hasbun, Rodrigo

Titel

Use of Testing for West Nile Virus and Other Arboviruses

Ist Teil von

• Emerging infectious diseases, 2016-09, Vol.22 (9), p.1587-1593

Ort / Verlag

United States: U.S. National Center for Infectious Diseases

Erscheinungsjahr

2016

Link zum Volltext

Quelle

EZB Free E-Journals

Beschreibungen/Notizen

• In the United States, the most commonly diagnosed arboviral disease is West Nile virus (WNV) infection. Diagnosis is made by detecting WNV IgG or viral genomic sequences in serum or cerebrospinal fluid. To determine frequency of this testing in WNV-endemic areas, we examined the proportion of tests ordered for patients with meningitis and encephalitis at 9 hospitals in Houston, Texas, USA. We identified 751 patients (567 adults, 184 children), among whom 390 (52%) experienced illness onset during WNV season (June-October). WNV testing was ordered for 281 (37%) of the 751; results indicated acute infection for 32 (11%). Characteristics associated with WNV testing were acute focal neurologic deficits; older age; magnetic resonance imaging; empirically prescribed antiviral therapy; worse clinical outcomes: and concomitant testing for mycobacterial, fungal, or other viral infections. Testing for WNV is underutilized, and testing of patients with more severe disease raises the possibility of diagnostic bias in epidemiologic studies.